Status:

COMPLETED

Age-Dependent Impact of the SYNTAX-score on Mortality

Lead Sponsor:

LMU Klinikum

Conditions:

Coronary Artery Disease

PCI

Eligibility:

All Genders

18+ years

Brief Summary

The SYNTAX-score has been proposed as a tool for risk stratification and guiding revascularization therapy in patients with complex coronary artery disease. There are limited data on the prognostic v...

Detailed Description

SYNTAX score has been used as a tool to quantify severity of coronary artery disease. Interventional or operative treatment of patients is associated with improvement in SYTAX score after PCI so calle...

Eligibility Criteria

Inclusion

  • patients undergoing PCI at our center

Exclusion

  • prior coronary artery bypass grafting
  • no PCI

Key Trial Info

Start Date :

January 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2016

Estimated Enrollment :

1331 Patients enrolled

Trial Details

Trial ID

NCT03479840

Start Date

January 1 2013

End Date

December 31 2016

Last Update

August 9 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ludwig-Maximilians University

Munich, Germany, 812377